Detailed Information on Publication Record
2022
Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
VAŠKŮ, Vladimír, Jan MÁCHAL, Filip ZLÁMAL and Anna VAŠKŮBasic information
Original name
Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
Authors
VAŠKŮ, Vladimír (203 Czech Republic, belonging to the institution), Jan MÁCHAL (203 Czech Republic, belonging to the institution), Filip ZLÁMAL (203 Czech Republic) and Anna VAŠKŮ (203 Czech Republic, guarantor, belonging to the institution)
Edition
Genes, BASEL, MDPI, 2022, 2073-4425
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30109 Pathology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.500
RIV identification code
RIV/00216224:14110/22:00128334
Organization unit
Faculty of Medicine
UT WoS
000902532500001
Keywords in English
skin T-cell lymphoma; mycosis fungoides; CTCL; polymorphism-MDR1
Tags
International impact, Reviewed
Změněno: 27/1/2023 14:08, Mgr. Tereza Miškechová
Abstract
V originále
Aim: Cutaneous T-cell lymphoma (CTCL) is a group of T-cell malignancies that develop in the skin. Though studied intensively, the etiology and pathogenesis of CTCL remain elusive. This study evaluated the survival of CTCL patients in the 1st Department of Dermatovenereology of St. Anne's University Hospital Brno. It included analysis of 19 polymorphic gene variants based on their expected involvement in CTCL severity. Material and methods: 75 patients with CTCL, evaluated and treated at the 1st Department of Dermatovenereology of St. Anne ' s University Hospital Brno, Faculty of Medicine, Masaryk University, were recruited for the study over the last 28 years (44 men and 31 women, average age 58 years, range 20-82 years). All patients were genotyped for 19 chosen gene polymorphisms by the conventional PCR method with restriction analysis. A multivariate Cox regression model was calculated to reveal genetic polymorphisms and other risk factors for survival. Results: The model identified MDR Ex21 2677 (rs2032582) as a significant genetic factor influencing the survival of the patients, with the T-allele playing a protective role. A multivariate stepwise Cox regression model confirmed the following as significant independent risk factors for overall survival: increased age at admission, clinical staging of the tumor, and male sex. Conclusion: We showed that the TT genotype at position 2677 of the MDR1 gene exhibited statistically significant longer survival in CTCL patients. As such, the TT genotype of MDR1 confers a significant advantage for the CTCL patients who respond to treatment.